Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's diseases

Journal of Comparative Neurology

Volumn 427, Issue 1, 2000, Pages 19-30

  Mufson, Elliott J ^a,c   Ma, Shuang Y ^a   Cochran, Elizabeth J ^a   Bennett, David A ^a   Beckett, Laural A ^a   Jaffar, Syed ^a   Saragovi, H Uri ^b   Kordower, Jeffrey H ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Cholinergic; Dementia; Nucleus basalis; Stereology; TrkA

Indexed keywords

APOLIPOPROTEIN E; PROTEIN DERIVATIVE; PROTEIN TYROSINE KINASE A; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CELL COUNT; CELL DENSITY; CELL LOSS; CLINICAL ARTICLE; COGNITIVE DEFECT; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; NERVE CELL; OLIVARY NUCLEUS; PERIKARYON; PRIORITY JOURNAL; STEREOLOGY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BASAL NUCLEUS OF MEYNERT; CELL COUNT; COGNITION DISORDERS; FEMALE; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NERVE DEGENERATION; NERVE GROWTH FACTOR; NEUROBEHAVIORAL MANIFESTATIONS; NEURONS; NEUROPSYCHOLOGICAL TESTS; RECEPTOR, TRKA; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0033809884     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9861(20001106)427:1<19::AID-CNE2>3.0.CO;2-A     Document Type: Article

References (91)

1. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease
2. Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype
3. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease
4. Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease
5. The cholinergic hypothesis of geriatric memory dysfunction
6. Around the WORLD backward: An algorithm for scoring the MMSE WORLD item
7. Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale
8. Dimensionality of parkinsonian signs in aging and Alzheimer's disease
9. Visuospatial judgment - A clinical test
10. Neurochemical correlates of dementia severity in Alzheimer's disease: Relative importance of the cholinergic deficits
11. Neuronal vulnerability and informatics in human disease
12. Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease
13. Keeping track of neurotrophin receptors
14. Choline acetyltransferase activity and histopathology of frontal neocortex from biospies of demented patients
15. Neuropathological staging of Alzheimer's-related changes
16. Geometria degli indivisigli
17. Severe panencephalic Pick's disease with Alzheimer's disease-like neuropil threads and synaptophysin immunoreactivity
18. Methods for determining numbers of cells and synapses: A case for more uniform standards of review
19. Trk receptor alterations in Alzheimer's disease
20. Incidental and intentional recall in Parkinson's disease: An account based on diminished attentional resources
21. A functional account of age differences in memory
22. Detection of NGF-like activity in human brain tissue: Increased levels in Alzheimer's disease
23. Selective loss of central cholinergic neurons in Alzheimer's disease
24. Cholinergic markers in elderly patients with early signs of Alzheimer disease
25. Cortical biopsy in Alzheimer's disease: Diagnostic accuracy and neurochemical, neuropathological and cogntive correlations
26. Analysis of choline acetyltransferase activity in cortex of individuals with mild cognitive impairment and Alzheimer's disease
27. Questionable dementia: Clinical course and predictors of outcome
28. Manual for kit of factor-referenced cognitive tests
29. Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys
30. Nucleus basalis neuronal loss, neuritic plaques and choline acetyl-transferase activity in advanced Alzheimer's disease
31. Mild cognitive impairment in the elderly: Predictors of dementia
32. 'Mini-mental state.' A practical method for grading the cognitive state of patients for the clinician
33. In situ hybridization detection of trkA mRNA in brain: Distribution, colocalization with p75NGFR and up-regulation by nerve growth factor
34. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease
35. The new stereological tools: Dissector, frqactionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis
36. Is Alzheimer's disease caused by a lack of nerve growth factor?
37. Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease
38. Human orbitofrontal cortex: Cyto-architecture and quantitative immunohistochemical parcellation
39. TrkA expression in the CNS: Evidence for the existence of several novel NGF-responsive CNS neurons
40. trk-Immunoreactivity in the monkey central nervous system: Forebrain
41. Potent human p140-TrkA agonists derived from an anti-receptor monoclonal antibody
42. Single section and disector counts in evaluating neuronal loss from the substantia nigra in patients with Parkinson's disease
43. Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts
44. Dopamine transporter immunoreactive neurons decrease with age in the human substantia nigra
45. Aging Alzheimer's disease, and the cholinergic system of the basal forebrain
46. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
47. Nucleus basalis (Ch4) and cortical cholinergic irmervation in the human brain: Observations based on the distribution of acetylcholinesterase and choline acetyltransferase
48. Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagnol band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey
49. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
50. CERAD Part I Clinical and neuropsychological assessment of Alzheimer's disease
51. Nerve growth factor and its receptors in the primate forebrain: Alterations in Alzheimer's disese and potential use in experimental therapeutics
52. Nerve growth factor in Alzheimer's disease
53. Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: A quantitative analysis across subregions of the basal forebrain
54. Nerve growth factor-like immunoreactive profiles in the primate basal forebrain and hippocampal formation
55. Nerve growth factor in Alzheimer's disease: Defective retrograde transport to nucleus basalis
56. Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease
57. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease
58. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment
59. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method
60. The cholinergic in old age and Alzheimer's disease
61. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals [published erratum appears in JAMA]
62. Diagnosis of dementia in a heterogeneous population A comparison of paradigm-based diagnosis and physician's diagnosis
63. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease
64. Apolipoprotein E4 allele as a predictor of cholinergic deficits a treatment outcome in Alzheimer's disease
65. Induction of apoptosis by the low-affinity NGF receptor
66. An NGF-TrkA-mediated retrograde signal to transcription factor CREB in sympathetic neurons
67. The predictive value of APOE genotyping in the elderly diagnosis of dementia of the Alzheimer's type: Data from threeindependent series
68. Very mild senile dementia of the Alzheimer type. I. Clinical assessment
69. Colocalization of high affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease
70. Nerve growth factor and Alzheimer's disease
71. Nerve growth factor in Alzheimer's disease: Increased levels throughout the brain coupled with declines in nucleus basalis
72. Reduction in trkA immunoreactive neurons is not associated with an overexpression of galanergic fibers within the nucleus basalis in Down's syndrome
73. Presynaptic cholinergic dysfunction in patients with dementia
74. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life Findings from the Nun Study
75. TrkA-immunoreactive profiles in the central nervous system: Colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin
76. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer's patients carrying an apolipoprotein epsilon 4 allele
77. Neuronal counts in the nucleus of Meynert in Alzheimer's disease and in simple senile dementia
78. Dementia: A brief and selective review
79. Cognitive functions of the basal forebrain cholinergic system in monkeys: Memory or attention?
80. Detection and staging of dementia in Alzheimer's disease: Use of the neuropsychological measures developed for CERAD
81. New stereological methods for counting neurons
82. Estimation of the number of somatostatin neurons in the striatum: An in situ hybridization study using the optical fractionator method
83. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain
84. Plaques, tangles and dementia A quantitative study
85. Estimating WAIS-R IQ from the National Adult Reading Test: A cross-validation
86. Change in cognitive function among older persons from a community population: Relation to age and Alzheimer's disease
87. Person-specific paths of cognitive decline in Alzheimer's disease and their relation to age